External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Respiratory ATS 2025
Roche and Genentech at

ATS 2025

May 17 - May 21
San Francisco, USA
conference.thoracic.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:27 PM
Duration 105mins San Francisco, USA
Poster : Serum soluble ST2 (sST2) is associated with chronic obstructive pulmonary disease (COPD) exacerbations and enhanced treatment response to astegolimab (anti-ST2)
Grimbaldeston MA, Li O, Flores A, Christenson SA, Woodruff PG, Cheung DS, Yousuf AJ, Greening NJ, Brightling CE, Staton TL, Choy DF
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 12mins San Francisco
Oral Presentation : Serum soluble ST2 (sST2) is associated with chronic obstructive pulmonary disease (COPD) exacerbations and enhanced treatment response to astegolimab (anti-ST2)
Grimbaldeston MA, Li O, Flores A, Christenson SA, Woodruff PG, Cheung DS, Yousuf AJ, Greening NJ, Brightling CE, Staton TL, Choy DF
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:15 PM
Duration 105mins San Francisco, USA
Reduced Host Antibacterial Function Is Associated with Type 2 Low Airway Disease
Movassagh H, Girgis H, Keilberg D, Mar JS, Peng C, Kofoed EM, Storek KM, Bradding P, Diver S, Hinks TSC, Choy DF
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 PM
Duration 105mins San Francisco, USA
All Cause and Chronic Obstructive Pulmonary Disease (COPD) Specific Readmission Rates in the US
Boudreau DM, Nebesky JM, Brightling CE, Lebovitch D, Martinez FJ, Samara K
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Francisco, USA
Oxidised human IL-33 does not appear to signal via the RAGE/EGFR receptor complex
Ramirez-Carrozzi V, Bewley K, Movassagh H, Choy D, El Sohly A, Pappu R
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 PM
Duration 105mins San Francisco, USA
Structural basis for inhibition of IL-33 Induced ST2 Activation by Astegolimab
Ravala SK, Dutka P, Bevers J, Wong M, Wong T, Corpuz R, Sudhamsu J
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.